Navigation Links
HCB Health Wins Manny Award for Best Medical Device Campaign
Date:5/11/2011

AUSTIN, Texas, May 11, 2011 /PRNewswire/ -- HCB Health, one of the top 25 independent healthcare communications agencies in the nation and the leading healthcare agency in the Southwest, won a Manny Award for best medical device campaign in the 22nd annual Manny Awards, a national competition honoring creative excellence in healthcare advertising. The award was presented for a consumer campaign supporting Sound Surgical Technologies' VASER® body shaping systems. Winners were announced by Med Ad News, sponsor of the awards, on April 28 at a gala ceremony at the Sheraton New York Hotel and Towers.

HCB's winning campaign uses tongue-in-cheek humor to underscore the benefits of VASER Lipo®, a minimally invasive procedure that uses a patented ultrasound technique to dramatically sculpt specific problem areas without harming vital tissues, and VASER® Shape, a non-invasive procedure that reduces the appearance of cellulite.

"Muffin top?" asks an ad featuring the curvy silhouette of a woman's torso: "VASER it," the copy advises. "Cankles?," "Saddle bags?," "Man boobs?," "Badonkadonk?" ask other ads in the series -- "VASER it," a memorable action all the ads urge.  

"We've used the human form in other VASER brand communications, but in this case we had fun with it, going with simple but intriguing graphics and playful language," said Amy Smith, account director at HCB. The campaign includes individual consumer ads as well as a VASER website with separate sections for consumers and physicians.

"We're honored to receive the Manny Award, and thankful to the editors of Med Ad News for recognizing our work," Smith said. "We're also thankful to Sound Surgical Technologies for their support and partnership in making the work possible," she added.

About HCB HealthHeadquartered in Austin, Tex., HCB Health serves the entire healthcare sector, including manufacturers of high-tech medical devices, high-science pharmaceuticals, diagnostics and genetic engineering products; physician groups, hospitals and managed care organizations; and patients and consumers.

One of the fastest growing agencies in its field, HCB Health has maintained a compounded 25 percent annual revenue growth since its inception in 2001. The agency posted a 40 percent increase in revenue from 2009 to 2010, adding eight new clients to its roster and nine new employees. The company also strengthened its broad range of capabilities, significantly expanding its digital and media services.HCB Health's clients, both domestic and global, include Alcon Labs, Medtronic, Sound Surgical Technologies LLC, Hollister, Cochlear Americas, the Menninger Clinic, Texas Oncology, US Oncology, LIVESTRONG, California Pacific Medical Center, Harden Healthcare, Entent Care, Optima Health, the Scott & White Health Plan, McKesson, Audiotoniq, and Austin Gastroenterology.

HCB Health is located at 701 Brazos St., Suite 1100, Austin, TX 78701. For more information, visit www.hcbhealth.com;  tel. (512) 320-8511, fax (512) 320-8990. CONTACT:Julie Laitin (212) 286-2424

Cynthia Amorese (908) 665-8072Email: jlaitin@julielaitin.com  

Email: camorese@comcast.net  
'/>"/>

SOURCE HCB Health
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Tone Deafness Explained, from the Harvard Health Letter
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
8. ViroPharma to Present at Three Upcoming Healthcare Conferences
9. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
10. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
11. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... NEW YORK , Feb. 22, 2017 This ... US$ Thousand. The report provides separate comprehensive analytics for the ... , Europe , Asia-Pacific ... World. Annual estimates and forecasts are provided for the period ... for these markets. Market data and analytics are derived from ...
(Date:2/23/2017)... England and DEERFIELD, Ill. ... U.S.A. , Inc., a wholly-owned subsidiary of ... a joint venture between Cambridge Cognition Holdings PLC and ... use of a specially designed app on an Apple ... patients with Major Depressive Disorder (MDD). Depression ...
(Date:2/23/2017)... , Feb. 23, 2017  CTI BioPharma Corp. ... management plans to report its fourth quarter and full ... the close of the U.S. financial markets. Following the ... webcast conference call to discuss the results and provide ... Access to the event can be obtained as follows: ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... CALNOC, the nation’s first and only ... their upcoming conference – Empowerment, Value and Collaboration – in Seattle, WA on October ... the Virginia Mason Health System in Seattle since 2000. In addition to his role ...
(Date:2/23/2017)... CHURCH, Va. (PRWEB) , ... February 23, 2017 , ... ... worries, or problems. He has also continued to spiritually evolve, which is the purpose ... published book “ Our Spiritual Truths ” (published by Balboa Press) attempts to guide ...
(Date:2/22/2017)... ... February 22, 2017 , ... The Waismann Method® ... of individuals who have recently fallen victim to America’s opioid epidemic. Now, opiate dependent ... California, where they are free from the shame, stigma, and harmful labeling ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... accurately understand each Medicare Advantage member’s risk, identify any gaps-in-coding, as well ... solution helps transform the HCC Risk Adjustment process from a typical fragmented ...
(Date:2/22/2017)... ... February 22, 2017 , ... THR ... “NANOCALM 300” Microemulsified Hemp Extract. This premier nanoemulsified CBD product utilizes Quicksilver ... the bloodstream. Far outpacing the absorption speed of all other products, ...
Breaking Medicine News(10 mins):